Article
TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function.
The Journal of biological chemistry - 10 Aug 2018
Cheng Qingwen, Danao Jean, Talreja Santosh, Wen Paul, Yin Jun, Sun Ning, Li Chi-Ming, Chui Danny, Tran David, Koirala Samir, Chen Hang, Foltz Ian N, Wang Songli, Sambashivan Shilpa
Abstract excerpt
Triggering receptor expressed on myeloid cells 2 (TREM2) is an orphan immune receptor expressed on cells of myeloid lineage such as macrophages and microglia. The rare variant R47H TREM2 is associated with an increased risk for Alzheimer's disease, supporting the hypothesis that TREM2 loss of function may exacerbate disease progression. However, a complete knockout of the TREM2 gene in different genetic models of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
